- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer ; volume:14 ; number:2 ; year:2021 ; pages:972-976 ; extent:5
Case reports in oncology ; 14, Heft 2 (2021), 972-976 (gesamt 5)
- Urheber
-
Denis, Chloé
Sakalihasan, Sarah
Frères, Pierre
Withofs, Nadia
Sautois, Brieuc
- DOI
-
10.1159/000517008
- URN
-
urn:nbn:de:101:1-2021090900453150417585
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Denis, Chloé
- Sakalihasan, Sarah
- Frères, Pierre
- Withofs, Nadia
- Sautois, Brieuc
Ähnliche Objekte (12)
Increased HRD score in cisplatin resistant penile cancer cells
New approaches for cisplatin-resistant bladder cancer
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
Penile cancer treatment costs in England
Surgical treatment of advanced penile cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Increased HRD score in cisplatin resistant penile cancer cells
New approaches for cisplatin-resistant bladder cancer
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
Penile cancer treatment costs in England
Surgical treatment of advanced penile cancer
Ureter metastatic castration-resistant prostate cancer: a case report
Increased HRD score in cisplatin resistant penile cancer cells
New approaches for cisplatin-resistant bladder cancer
Verminoside from Pseudolysimachion rotundum var. subintegrum sensitizes cisplatin-resistant cancer cells and suppresses metastatic growth of human breast cancer
Promising Novel Therapeutic Strategies for Cisplatin Resistant Bladder Cancer
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Resistant metastatic penile carcinoma and response to biochemotherapy with paclitaxel and epidermal growth factor receptor monoclonal antibody, nimotuzumab
Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
Penile cancer treatment costs in England
Surgical treatment of advanced penile cancer